-
公开(公告)号:EP0267378B1
公开(公告)日:1992-11-04
申请号:EP87112029.1
申请日:1987-08-19
IPC分类号: A61K31/12 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/34 , A61K31/26 , A61K31/335
CPC分类号: A61K31/12 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/26 , A61K31/335 , A61K31/34
-
公开(公告)号:EP0267378A2
公开(公告)日:1988-05-18
申请号:EP87112029.1
申请日:1987-08-19
IPC分类号: A61K31/12 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/34 , A61K31/26 , A61K31/335
CPC分类号: A61K31/12 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/26 , A61K31/335 , A61K31/34
摘要: An anti-mycoplasma agent comprising tropolone, its derivatives, represented by the formula;
(wherein R₁ is hydroxy, aliphatic acyloxy, arylacyloxy, arysulfonyloxy, carboxyalkyloxy or its ester, benzoylalkyloxy, alkenyloxy, 1,3-dihydro-3-oxo-1-isobenzofuranyloxy, (2-oxo-5-methyl-1,3-dioxol-4-yl)methyloxy or thiocyanato and R₂ is hydrogen, halogen, hydroxy, alkyl or alkoxy)
and their salts as an active ingredient, which has potent activity especially against tylosin-resistant mycoplasma both in vitro and in vivo and is effectively used in treating the diseases caused thereby.摘要翻译: 一种抗支原体剂,其包含由式表示的扑普龙,其衍生物;
(其中R1是羟基,脂族酰氧基,芳基酰氧基,芳磺酰氧基,羧基烷氧基或其酯,苯甲酰基烷氧基,烯氧基,1,3-二氢-3-氧代-1-异苯并呋喃基氧基,(2-氧代-5-甲基-1, 3-二氧杂环戊烯-4-基)甲氧基或硫氰酸酯,R 2是氢,卤素,羟基,烷基或烷氧基)及其盐作为活性成分,其在体外和体内都特别有效地抵抗泰乐菌素抗性支原体,并且是 有效地用于治疗由此引起的疾病。 -
公开(公告)号:EP0267378A3
公开(公告)日:1990-04-25
申请号:EP87112029.1
申请日:1987-08-19
IPC分类号: A61K31/12 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/34 , A61K31/26 , A61K31/335
CPC分类号: A61K31/12 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/26 , A61K31/335 , A61K31/34
摘要: An anti-mycoplasma agent comprising tropolone, its derivatives, represented by the formula;
(wherein R₁ is hydroxy, aliphatic acyloxy, arylacyloxy, arysulfonyloxy, carboxyalkyloxy or its ester, benzoylalkyloxy, alkenyloxy, 1,3-dihydro-3-oxo-1-isobenzofuranyloxy, (2-oxo-5-methyl-1,3-dioxol-4-yl)methyloxy or thiocyanato and R₂ is hydrogen, halogen, hydroxy, alkyl or alkoxy)
and their salts as an active ingredient, which has potent activity especially against tylosin-resistant mycoplasma both in vitro and in vivo and is effectively used in treating the diseases caused thereby.
-
-